Endometrial progesterone resistance and PCOS

Journal of Biomedical Science

Volumn 21, Issue 1, 2014, Pages

  Li, Xin ^a,b   Feng, Yi ^a,b   Lin, Jin Fang ^b   Billig, Håkan ^a   Shao, Ruijin ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b FUDAN UNIVERSITY   (China)

Author keywords

Endometrium; PCOS; Progesterone receptor isoforms; Progesterone resistance

Indexed keywords

PROGESTERONE;

BIOSYNTHESIS; CONGENITAL MALFORMATION; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; OVARY POLYCYSTIC DISEASE; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION; UTERUS DISEASE;

ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; POLYCYSTIC OVARY SYNDROME; PROGESTERONE; SIGNAL TRANSDUCTION; UTERINE DISEASES;

EID: 84893830764     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-21-2     Document Type: Article

References (57)

1. Polycystic ovary syndrome. Norman RJ, Dewailly D, Legro RS, Hickey TE, Lancet 2007 370 685 697 10.1016/S0140-6736(07)61345-2 17720020 (Pubitemid 47285318)
2. Lifestyle changes in women with polycystic ovary syndrome. Moran LJ, Hutchison SK, Norman RJ, Teede HJ, Cochrane Database Syst Rev 2011 2 D007506 21328294
3. Polycystic ovary syndrome. Ehrmann DA, N Engl J Med 2005 352 12 1223 1236 10.1056/NEJMra041536 15788499 (Pubitemid 40397264)
4. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, Hum Reprod 2004 19 41 47 14688154
5. Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Homburg R, Best Prac Res Clin Obstet Gynaecol 2004 18 773 788 10.1016/j.bpobgyn.2004.05.006 (Pubitemid 40424610)
6. Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance. Chakraborty P, Goswami SK, Rajani S, Sharma S, Kabir SN, Chakravarty B, Jana K, PLoS One 2013 8 64446 10.1371/journal.pone.0064446 23700477
7. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S, Reprod Biomed Online 2009 19 398 405 10.1016/S1472-6483(10)60175-7 19778486
8. Polycystic ovary syndrome and endometrial carcinoma. Hardiman P, Pillay OC, Atiomo W, Lancet 2003 361 1810 1812 10.1016/S0140-6736(03)13409-5 12781553 (Pubitemid 36638434)
9. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study. Fearnley EJ, Marquart L, Spurdle AB, Weinstein P, Webb PM, Cancer Causes Control 2010 21 2303 2308 10.1007/s10552-010-9658-7 20953904
10. Physiological action of progesterone in target tissues. Graham JD, Clarke CL, Endocr Rev 1997 18 502 519 9267762 (Pubitemid 27349554)
11. The progesterone receptor regulates implantation, decidualization, and glandular development via a complex paracrine signaling network. Wetendorf M, DeMayo FJ, Mol Cell Endocrinol 2012 357 108 118 10.1016/j.mce.2011.10.028 22115959
12. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Kim JJ, Kurita T, Bulun SE, Endocr Rev 2013 34 130 162 10.1210/er.2012-1043 23303565
13. Hormone receptor dynamics in a receptive human endometrium. Critchley HO, Saunders PT, Reprod Sci 2009 16 191 199 10.1177/1933719108331121 19208787
14. Progesterone resistance. Chrousos GP, MacLusky NJ, Brandon DD, Tomita M, Renquist DM, Loriaux DL, Lipsett MB, Adv Exp Med Biol 1986 196 317 328 10.1007/978-1-4684-5101-6-21 3087144
15. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives. Shen ZQ, Zhu HT, Lin JF, Obstet Gynecol 2008 112 465 467 10.1097/AOG.0b013e3181719b92 18669766
16. Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. Savaris RF, Groll JM, Young SL, DeMayo FJ, Jeong JW, Hamilton AE, Giudice LC, Lessey BA, J Clin Endocrinol Metab 2011 96 1737 1746 10.1210/jc.2010-2600 21411543
17. Endometrial thickness, uterine, and ovarian ultrasonographic features in adolescents with polycystic ovarian syndrome. Shah B, Parnell L, Milla S, Kessler M, David R, J Pediatr Adolesc Gynecol 2010 23 146 152 10.1016/j.jpag.2009.07.002 19733099
18. Mechanisms of endometrial progesterone resistance. Al-Sabbagh M, Lam EW, Brosens JJ, Mol Cell Endocrinol 2012 358 208 215 10.1016/j.mce.2011.10.035 22085558
19. Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome. Kim JY, Song H, Kim H, Kang HJ, Jun JH, Hong SR, Koong MK, Kim IS, J Clin Endocrinol Metab 2009 94 1416 1426 10.1210/jc.2008-1612 19141577
20. Unfolding the action of progesterone receptors. Li X, O'Malley BW, J Biol Chem 2003 278 39261 39264 10.1074/jbc.R300024200 12893816 (Pubitemid 37248479)
21. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P, EMBO J 1990 9 1603 1614 2328727
22. Reproductive functions of progesterone receptors. Conneely OM, Mulac-Jericevic B, DeMayo F, Lydon JP, O'Malley BW, Recent Prog Horm Res 2002 57 339 355 10.1210/rp.57.1.339 12017551
23. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay. Leonhardt SA, Altmann M, Edwards DP, Mol Endocrinol 1998 12 1914 1930 10.1210/mend.12.12.0210 9849965 (Pubitemid 28544186)
24. Nuclear progesterone receptor A and B isoforms in mouse fallopian tube and uterus: implications for expression, regulation, and cellular function. Shao R, Weijdegard B, Ljungstrom K, Friberg A, Zhu C, Wang X, Zhu Y, Fernandez-Rodriguez J, Egecioglu E, Rung E, et al. Am J Physiol Endocrinol Metab 2006 291 59 E72 10.1152/ajpendo.00582.2005 16449295 (Pubitemid 44035310)
25. Systematic expression analysis and antibody screening do not support the existence of naturally occurring progesterone receptor (PR)-C, PR-M, or other truncated PR isoforms. Samalecos A, Gellersen B, Endocrinology 2008 149 5872 5887 10.1210/en.2008-0602 18617611
26. Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function. Condon JC, Hardy DB, Kovaric K, Mendelson CR, Mol Endocrinol 2006 20 764 775 10.1210/me.2005-0242 16339279
27. Non-genomic progesterone actions in female reproduction. Gellersen B, Fernandes MS, Brosens JJ, Hum Reprod Update 2009 15 119 138 18936037
28. Regulated expression of putative membrane progestin receptor homologues in human endometrium and gestational tissues. Fernandes MS, Pierron V, Michalovich D, Astle S, Thornton S, Peltoketo H, Lam EW, Gellersen B, Huhtaniemi I, Allen J, et al. J Endocrinol 2005 187 89 101 10.1677/joe.1.06242 16214944 (Pubitemid 41556404)
29. Mechanisms of implantation: strategies for successful pregnancy. Cha J, Sun X, Dey SK, Nat Med 2012 18 1754 1767 10.1038/nm.3012 23223073
30. Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. Mote PA, Balleine RL, McGowan EM, Clarke CL, J Clin Endocrinol Metab 1999 84 2963 2971 10443705 (Pubitemid 30642036)
31. Coordinate regulation of heterogeneous nuclear ribonucleoprotein dynamics by steroid hormones in the human Fallopian tube and endometrium in vivo and in vitro. Shao R, Wang X, Weijdegard B, Norstrom A, Fernandez-Rodriguez J, Brannstrom M, Billig H, Am J Physiol Endocrinol Metab 2012 302 1269 E1282 10.1152/ajpendo.00673.2011 22436695
32. Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma. Mote PA, Balleine RL, McGowan EM, Clarke CL, Hum Reprod 2000 15 Suppl 3 48 56 10.1093/humrep/15.suppl-3.48 11041221
33. MUC1 as a discriminator between endometrium from fertile and infertile patients with PCOS and endometriosis. Margarit L, Taylor A, Roberts MH, Hopkins L, Davies C, Brenton AG, Conlan RS, Bunkheila A, Joels L, White JO, et al. J Clin Endocrinol Metab 2010 95 5320 5329 10.1210/jc.2010-0603 20826587
34. Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome. Quezada S, Avellaira C, Johnson MC, Gabler F, Fuentes A, Vega M, Fertil Steril 2006 85 1017 1026 10.1016/j.fertnstert.2005.09.053 16580389
35. The knockdown of progesterone receptor isoform B (PR-B) promotes proliferation in immortalized endometrial stromal cells. Wu Y, Shi X, Guo SW, Fertil Steril 2008 90 1320 1323 10.1016/j.fertnstert.2007.10.049 18249378
36. Estrogen receptors and human disease. Deroo BJ, Korach KS, J Clin Invest 2006 116 561 570 10.1172/JCI27987 16511588 (Pubitemid 43326860)
37. Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus. Weihua Z, Saji S, Makinen S, Cheng G, Jensen EV, Warner M, Gustafsson JA, Proc Natl Acad Sci U S A 2000 97 5936 5941 10.1073/pnas.97.11.5936 10823946 (Pubitemid 30367502)
38. Progestin activation of nongenomic pathways via cross talk of progesterone receptor with estrogen receptor beta induces proliferation of endometrial stromal cells. Vallejo G, Ballare C, Baranao JL, Beato M, Saragueta P, Mol Endocrinol 2005 19 3023 3037 10.1210/me.2005-0016 16020483 (Pubitemid 41699783)
39. Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle. Mangal RK, Wiehle RD, Poindexter AN 3rd, Weigel NL, J Steroid Biochem Mol Biol 1997 63 195 202 10.1016/S0960-0760(97)00119-2 9459185 (Pubitemid 28137157)
40. Expression of GPR30, ERalpha and ERbeta in endometrium during window of implantation in patients with polycystic ovary syndrome: a pilot study. Wang A, Ji L, Shang W, Li M, Chen L, White RE, Han G, Gynecol Endocrinol 2011 27 251 255 10.3109/09513590.2010.487584 21269226
41. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, Lessey BA, Giudice LC, Endocrinology 2007 148 3814 3826 10.1210/en.2006-1692 17510236 (Pubitemid 47105847)
42. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Bulun SE, Cheng YH, Pavone ME, Xue Q, Attar E, Trukhacheva E, Tokunaga H, Utsunomiya H, Yin P, Luo X, et al. Semin Reprod Med 2010 28 36 43 10.1055/s-0029-1242991 20104427
43. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Wheeler DT, Bristow RE, Kurman RJ, Am J Surg Pathol 2007 31 988 998 10.1097/PAS.0b013e31802d68ce 17592264 (Pubitemid 47012294)
44. Combined oral contraceptives in the treatment of polycystic ovary syndrome. Vrbikova J, Cibula D, Hum Reprod Update 2005 11 277 291 10.1093/humupd/dmi005 15790599 (Pubitemid 40668112)
45. Altered gene expression profiling in endometrium: evidence for progesterone resistance. Aghajanova L, Velarde MC, Giudice LC, Semin Reprod Med 2010 28 51 58 10.1055/s-0029-1242994 20104428
46. Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy. Janzen DM, Rosales MA, Paik DY, Lee DS, Smith DA, Witte ON, Iruela-Arispe ML, Memarzadeh S, Cancer Res 2013 73 4697 4710 10.1158/0008-5472.CAN-13-0930 23744837
47. Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent. Session DR, Kalli KR, Tummon IS, Damario MA, Dumesic DA, Gynecol Endocrinol 2003 17 405 407 10.1080/09513590312331290298 14710588 (Pubitemid 37338871)
48. Sex steroids and insulin resistance. Livingstone C, Collison M, Clin Sci (Lond) 2002 102 151 166 10.1042/CS20010197 11834135 (Pubitemid 34185043)
49. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Arnett-Mansfield RL, de Fazio A, Wain GV, Jaworski RC, Byth K, Mote PA, Clarke CL, Cancer Res 2001 61 4576 4582 11389093 (Pubitemid 32685792)
50. Metformin suppresses interleukin (IL)-1beta-induced IL-8 production, aromatase activation, and proliferation of endometriotic stromal cells. Takemura Y, Osuga Y, Yoshino O, Hasegawa A, Hirata T, Hirota Y, Nose E, Morimoto C, Harada M, Koga K, et al. J Clin Endocrinol Metab 2007 92 3213 3218 10.1210/jc.2006-2486 17504902 (Pubitemid 47236394)
51. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells. Xie Y, Wang YL, Yu L, Hu Q, Ji L, Zhang Y, Liao QP, J Steroid Biochem Mol Biol 2011 126 113 120 10.1016/j.jsbmb.2010.12.006 21168492
52. Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression. Dong L, Zhou Q, Zhang Z, Zhu Y, Duan T, Feng Y, J Obstet Gynaecol Res 2012 38 1077 1085 10.1111/j.1447-0756.2011.01839.x 22540333
53. Does metformin influence the insulin-, IGF I- and IGF II-receptor gene expression and Akt phosphorylation in human decidualized endometrial stromal cells? Capp E, Jauckus J, von Eye Corleta H, Toth B, Strowitzki T, Germeyer A, Eur J Obstet Gynecol Reprod Biol 2011 158 248 253 10.1016/j.ejogrb.2011.05.012 21664031
54. Metformin modulates IL-8, IL-1beta, ICAM and IGFBP-1 expression in human endometrial stromal cells. Germeyer A, Jauckus J, Zorn M, Toth B, Capp E, Strowitzki T, Reprod Biomed Online 2011 22 327 334 10.1016/j.rbmo.2010.11.006 21316309
55. Steroid and peptide regulation of insulin-like growth factor-binding proteins secreted by human endometrial stromal cells is dependent on stromal differentiation. Giudice LC, Dsupin BA, Irwin JC, J Clin Endocrinol Metab 1992 75 1235 1241 1385468
56. The influence of insulin on secretion of IGF-I and IGFBP-I in cultures of human endometrial stromal cells. Lin J, Li R, Zhou J, Chin Med J 2003 116 301 304 12775252 (Pubitemid 36504069)
57. Endometrial abnormality in women with polycystic ovary syndrome. Shang K, Jia X, Qiao J, Kang J, Guan Y, Reprod Sci 2012 19 674 683 10.1177/ 1933719111430993 22534323